➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Harvard Business School
Mallinckrodt
McKesson
McKinsey

Last Updated: February 24, 2021

DrugPatentWatch Database Preview

TELMISARTAN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Telmisartan, and when can generic versions of Telmisartan launch?

Telmisartan is a drug marketed by Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Celltrion, Glenmark Pharms Ltd, Hetero Labs Ltd V, Hisun Pharm Hangzhou, Inventia, Jubilant Generics, Micro Labs, Mylan, Prinston Inc, Sandoz Inc, Torrent, Zydus Pharms, Lupin Ltd, and Macleods Pharms Ltd. and is included in twenty-nine NDAs.

The generic ingredient in TELMISARTAN is hydrochlorothiazide; telmisartan. There are thirty-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.

Drug patent expirations by year for TELMISARTAN
Drug Prices for TELMISARTAN

See drug prices for TELMISARTAN

Drug Sales Revenue Trends for TELMISARTAN

See drug sales revenues for TELMISARTAN

Recent Clinical Trials for TELMISARTAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Queens Medical CenterPhase 2
Cairo UniversityN/A
George Medicines PTY LimitedPhase 3

See all TELMISARTAN clinical trials

Pharmacology for TELMISARTAN
Paragraph IV (Patent) Challenges for TELMISARTAN
Tradename Dosage Ingredient NDA Submissiondate
MICARDIS TABLET;ORAL telmisartan 020850 2006-12-26

US Patents and Regulatory Information for TELMISARTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd TELMISARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; telmisartan TABLET;ORAL 202544-002 Mar 4, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz Inc TELMISARTAN telmisartan TABLET;ORAL 203867-002 Nov 3, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Micro Labs TELMISARTAN telmisartan TABLET;ORAL 207016-002 Oct 3, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Torrent TELMISARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; telmisartan TABLET;ORAL 201192-001 Feb 25, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Alembic Pharms Ltd TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 205234-001 Nov 17, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Mallinckrodt
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.